January 23, 2018 / 1:14 PM / 9 months ago

BRIEF-Biocancell Announces Terms Of $25 Million Funding Round

Jan 23 (Reuters) - Biocancell Ltd:

* BIOCANCELL ANNOUNCES TERMS OF $25 MILLION FUNDING ROUND

* BIOCANCELL LTD - EXECUTED NON-BINDING TERM SHEET FOR PRIVATE EQUITY INVESTMENT IN CO OF ABOUT $25 MILLION; INVESTMENT WILL BE PRICED AT NIS 1.60 PER SHARE​

* BIOCANCELL LTD - ‍FUNDRAISING PLANS ARE DESIGNED TO FUND CO’S INITIATION OF CLINICAL TRIALS OF BC-819 IN EARLY STAGE BLADDER CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below